Explore every episode of the podcast The Science of Age-less Living

What separates someone managing a pharmacy's worth of medications at seventy-five from someone who's just getting started on the road to a hundred and two? In this episode, we crack open the biological instruction manual of the world's centenarians and read its most remarkable pages. We start with a crucial distinction — the difference between lifespan (how long you live) and healthspan (how long you live well) — and the striking pattern researchers call the compression of morbidity: the way the very longest-lived people tend to stay healthy far longer and then decline quickly, burning clean and steady rather than guttering out over decades.

From there, we tour the genes that show up again and again in centenarian studies across the globe. We meet APOE, the double-edged gene whose different versions tilt the odds toward risk or protection; FOXO3, the "building superintendent" that switches on your cells' repair, cleanup, and recycling crews; and the counterintuitive growth paradox of IGF-1 and mTOR, where dialing down the body's relentless "grow!" signal turns out to favor a longer, more durable life. We round out the cast with Klotho, the DNA-repair scribes that keep your genetic manuscript faithful over a lifetime, and the immune-signaling genes that know when to stand inflammation down instead of letting it smolder into "inflammaging."

But the real payoff isn't a list of genes you either have or don't. It's the single idea underneath all of them: genetics loads the gun, but lifestyle pulls the trigger. Many of the exact pathways centenarians inherit for free — maintenance, repair, restraint, regulation — have handles that your daily choices can reach, through movement, sleep, the rhythm of eating, and managing chronic inflammation. You can't swap your DNA, but you can influence which genes are switched on and how loudly. This episode is about learning where those dimmer switches are, and why aging age-lessly was never a locked door.

Most people treat sleep as simple recovery, but this episode reframes it as the nightly window in which a gland smaller than a pea helps decide how fast you age. That gland is the pineal gland, buried at the center of your brain, and its job is to release melatonin — not really a "sleep chemical" but a darkness signal that tells every cell in your body it's night. This signal is wired to light hitting your eyes and routed through your brain's master clock, the SCN. The catch: the pineal gland tends to calcify and its melatonin output declines with age, so the darkness signal that once washed cleanly through your body every night grows quieter over the decades.

That fading signal matters because you don't have one clock — you have trillions. Nearly every cell runs its own roughly-24-hour rhythm built from "clock genes," and those genes control the timing of a huge share of what your body does, from DNA repair to metabolism to immune activity. Melatonin helps keep all these clocks synchronized. When chronic stress and poor sleep scramble that synchronization, gene expression shifts: the inflammation program (driven by NF-κB) creeps on, while repair-and-protection systems tied to the clock — like the longevity-linked SIRT1 — get thrown off schedule. Crucially, none of this mutates your DNA; it changes which genes are switched on and off through epigenetic "bookmarks" that respond to how you live.

The hopeful takeaway is that because these are shifts in gene expression rather than permanent damage, much of it responds to daily behavior. The episode's highest-leverage moves are unglamorous and free: get bright light into your eyes early in the morning, defend real darkness in the hour before bed, keep your sleep timing consistent, and wind down evening stress so your cortisol rhythm stays intact. Melatonin supplements are framed honestly as a timing tool, not a proven anti-aging cure. The through-line is the show's core promise — that the most powerful levers on aging are often the quietest ones you already control.

The GLP-1 receptor agonists are the most effective weight loss agents ever brought to market, and their efficacy is entirely contingent on continued administration. Three randomized withdrawal studies across two molecules make this unambiguous: the STEP-1 extension found participants regained roughly two-thirds of their lost weight within a year of stopping, with blood pressure, lipids, glycaemia and inflammatory markers reverting alongside it. STEP-4 and SURMOUNT-4 showed the same pattern under cleaner designs, with the gap between continuing and stopping running to fifteen percentage points of body weight in under a year. The science of getting onto these drugs is mature. The science of getting off them is roughly a decade behind.

This episode explains why, and the answer is physiological rather than behavioral. Weight loss of any kind provokes a coordinated defense — leptin falls disproportionately, ghrelin rises above pre-treatment levels, satiety peptides decline, and energy expenditure adapts downward — and that response persists for at least a year. Throughout treatment, the drug doesn't resolve this counter-regulation; it masks it by agonizing the same receptors the system uses to signal satiety. Withdraw the drug and what emerges isn't the patient's old appetite. It's the unopposed appetite of a person who has just lost fifteen percent of their body weight. Compounding this is an asymmetry in body composition: lean tissue is lost readily and regained poorly, so a completed cycle returns the patient to their starting weight with a worse ratio — a trajectory that runs directly counter to healthy aging.

We work through the pharmacology properly — albumin-binding, hypothalamic melanocortin signaling, dual GIP/GLP-1 agonism, the mesolimbic reward effects — then take the off-ramp strategies one at a time and label the evidence for each honestly: chronic therapy, maintenance dosing, tapering, bridging technologies like Fractyl's duodenal resurfacing, and the next-generation oral and triple agonists. Most of what is currently done in clinical practice rests on mechanistic reasoning rather than trial data, and the distinction matters. The conclusion is straightforward: these drugs are a chronic therapy for a chronic condition, not a course of treatment, and anyone presenting them as a finite intervention with a permanent result is either not reading the withdrawal trials or choosing not to mention them.

Episode summary

Cerebrolysin is a peptide preparation with a strange résumé: developed in Austria more than sixty years ago, approved in nearly fifty countries for stroke, traumatic brain injury, and dementia, put through hundreds of clinical trials — and yet still surrounded by a genuinely unresolved question about whether it works. In this episode we unpack what it actually is (not a single peptide, but a standardized mixture of amino acids and small fragments made by enzymatically digesting pig brain tissue), the one clever idea at its core (fragments small enough to slip across the blood-brain barrier and mimic the brain's own neurotrophic factors like BDNF and NGF), and the crucial gap between an effect in a lab dish and a real benefit in a human being.

Then we get to the part the marketing skips. A 2023 systematic review found Cerebrolysin likely offers no benefit for survival in acute ischemic stroke and may even raise the rate of serious adverse events — and much of the supportive research has been funded by the manufacturer. We also cover the uncomfortable reality behind the vials sold online: it's not FDA-approved in the US, and the "research use only" label is a legal workaround for shipping an unregulated injectable with no purity or sterility guarantees. The takeaway is neither hype nor dismissal — Cerebrolysin is a genuinely interesting compound aimed at a real target, but the honest evidence says it's worth watching, not worth self-experimenting on with a needle. As always: not medical advice, and a real conversation for a licensed physician.

Episode summary

Right now, inside every cell in your body, trillions of microscopic factories are assembling molecules called peptides — the short chains of amino acids your body uses to talk to itself, from insulin to oxytocin. But how does your body actually build one? In this episode we follow a single peptide all the way from blueprint to finished product, using the real scientific terms but giving you a picture for every one. We start in the "library" of your DNA, where each recipe is written in three-letter words called codons, then watch the cell make a disposable photocopy — messenger RNA — so the precious original never has to leave. That copy travels to the ribosome, the cell's assembly line, where a fleet of molecular "delivery trucks" brings exactly the right amino acids and snaps them into a chain, bead by bead.

But coming off the assembly line isn't the finish line. We walk through the finishing shop — where the floppy chain folds into its working shape, gets reinforced with molecular "staples," and is often trimmed down from an oversized version (the surprising way your body actually builds insulin) — and then the packaging and shipping department that releases the final peptide out into your body. We close by zooming out to nature's other method of building peptides without a ribosome at all (the route behind many antibiotics), and how humans manufacture peptides ourselves, from building them one bead at a time in the lab to turning engineered bacteria into living insulin factories. By the end, you'll understand one of the most elegant manufacturing processes in the known universe — the one that's been running inside you your whole life.

LL-37 is the odd one out in the Age-Less peptide series. Where Humanin and MOTS-c were mitochondrial longevity signals, LL-37 is the human cathelicidin — your body's own broad-spectrum antibiotic, a small positively charged peptide cut from a larger precursor and stationed at every barrier where you meet the outside world. Dr. Ethan walks through what it actually is: how it's encoded, how it's stored and released, and how that little two-faced helix kills bacteria on contact, neutralizes endotoxin, recruits immune cells, heals wounds, and links your innate immunity to your vitamin D status.

Then he turns the coin over. LL-37 is genuinely double-edged — a superb defender when it fires correctly, and a documented driver of disease when it doesn't. This episode lays out the mechanisms behind its role in psoriasis, rosacea, and lupus, explains why "more is better" is exactly the wrong instinct here, and separates the strong evidence for your own endogenous LL-37 from the thin, narrow evidence for LL-37 as an administered therapy. Along the way: the real vitamin D connection (and why supplementing on top of sufficiency won't reliably raise it), and why a regulator has specifically flagged this molecule as a safety concern.

The honest bottom line runs opposite to the marketing. This isn't a level to chase or a peptide to inject — it's a system to keep in good working order. No hype, no discount codes: just what LL-37 is, what it does, what the human data shows, and what the regulatory picture actually looks like in 2026.

One note: I kept the title's framing accurate to the science (the "shouldn't inject" line reflects the real safety picture, not editorializing). If you'd prefer something shorter or more neutral for a feed, say the word and I'll trim it.

In this episode of The Science of Age-less Living, Dr. Ethan Hausman-Marquis unpacks Humanin — a molecule with one of the most remarkable origin stories in longevity science. Discovered in 2001 in the surviving neurons of an Alzheimer's-affected brain, Humanin turned out to be encoded not in our nuclear DNA but inside the mitochondrial genome, making it the founding member of an entirely new class of molecules: the mitochondrial-derived peptides. It reframed the mitochondrion as more than a power plant — as a sensor that, under stress, sends peptide messages to the rest of the body. Dr. Hausman-Marquis walks through what Humanin actually is, its two forms, and its well-characterized protective biology: blocking apoptosis by neutralizing pro-death Bcl-2 proteins, signaling through a trimeric cell-surface receptor to activate survival pathways, engaging the IGF-1 axis, and improving insulin sensitivity.

Then comes the honest reckoning. Humanin declines substantially with age, tracks with better outcomes in observational data, and runs high in the children of centenarians — but the human evidence largely stops there. There are no completed efficacy trials, no approved product, and no established dose, and much of the most impressive preclinical work relied on a synthetic analog roughly a thousand times more potent than the natural peptide. The episode separates the compelling biology from the near-blank clinical page, covers the evidence-based ways to support Humanin naturally — exercise, caloric discipline, and mitochondrial health — and closes with a look ahead to MOTS-c, the second major mitochondrial-derived peptide. No hype, no discount codes — just the science, as it actually stands in 2026.

SS-31 — also known as elamipretide — occupies a category no other compound in this series can claim: it is the first mitochondria-targeted therapy ever to receive FDA approval. In this episode, Dr. Ethan traces the compound from its accidental discovery in a Weill Cornell pharmacology lab through to its September 2025 accelerated approval for Barth syndrome, unpacking the biology of cardiolipin — the inner mitochondrial membrane phospholipid whose decline with age sits at the centre of SS-31's entire mechanistic rationale — and explaining precisely why a peptide that concentrates over 1,000-fold inside the mitochondrial membrane represents a genuinely novel class of therapeutic tool. The mechanism is well-supported, the preclinical literature is large and independently replicated, and the clinical trial programme is the most rigorous of any compound covered in this series so far.

The honest picture is more nuanced than the approval alone would suggest. The regulatory journey was long and difficult — an initial refusal to file, a subsequent rejection, and an eventual accelerated approval based on an intermediate endpoint in a rare paediatric disease population. The heart failure and AMD programmes remain in active development, not yet approved. And for the application most longevity-focused listeners are actually interested in — preserving mitochondrial function in a healthy ageing adult — there are no completed trials and no approved protocols. Dr. Ethan draws a precise line between what the approval actually means, what the active trial pipeline shows, and where the extrapolation to healthy ageing begins — and explains why SS-31 is simultaneously the most clinically credible mitochondrial compound in the longevity space and still some distance from a validated longevity intervention.

Pinealon is one of the least discussed compounds in mainstream longevity medicine — and that obscurity is itself worth examining. Derived from pineal gland tissue and developed within a serious, decades-long Russian bioregulatory peptide research programme, it sits at the intersection of two of the most compelling areas in ageing biology: the decline of the pineal gland as a master regulator of circadian timing, and the emerging science of epigenetic modulation as a mechanism for restoring youthful gene expression patterns in ageing neurons. In this episode, Dr. Ethan Hausman-Marquis traces Pinealon from its origins in the St. Petersburg school of biogerontology through to its proposed mechanisms — BDNF-adjacent neuroprotection, circadian clock gene modulation, and a genuinely novel hypothesis about direct peptide-DNA interaction — and examines what the preclinical evidence actually shows.

The honest answer is that Pinealon's evidence base is the thinnest in this series so far — geographically concentrated, not independently replicated, and nowhere near randomised controlled trial territory for any indication. But the biological target is one of the most legitimate in longevity medicine, and the mechanistic hypothesis, if it survives independent scrutiny, would represent something genuinely new in the neuroprotection space. This episode draws a precise line between what is established, what is plausible, and what remains speculation — and explains why the right response to Pinealon in 2026 is neither clinical enthusiasm nor dismissal, but a structured research agenda that has not yet been built.

SEMAX is one of the most discussed cognitive compounds in the longevity and nootropic world — and arguably one of the most poorly understood. In this episode, Dr. Ethan does what this series always does: follows the science wherever it leads, without the hype and without the dismissiveness.

The story of SEMAX starts not in a supplement company's marketing department, but in a Soviet government research institute in the 1980s, where neuropeptide scientists were asking a genuinely interesting question: could fragments of ACTH — the pituitary hormone best known for driving cortisol production — exert direct effects on the brain entirely independent of the adrenal axis? The answer was yes. And SEMAX was the engineered result: a stable, intranasally bioavailable heptapeptide designed to deliver those neuropeptide effects to the central nervous system.

The mechanistic story is one of the more coherent in this series. SEMAX upregulates BDNF — brain-derived neurotrophic factor — in hippocampal and prefrontal circuits, the very regions most implicated in age-related cognitive decline. It modulates serotonin availability. It attenuates neuroinflammatory cascades. Each of those mechanisms has a plausible link to cognitive ageing, and together they form a rational basis for the compound's proposed effects.

The evidence picture is more complicated. SEMAX has genuine peer-reviewed data — animal studies, Russian clinical trials in stroke and cerebrovascular disease, a 40-year research history. It is a licensed pharmaceutical in Russia, not a grey-market research chemical. But the clinical data has real structural limitations, and for the application most listeners are actually interested in — sharper cognition in a healthy ageing adult — the human randomised controlled trial evidence does not yet exist.

Dr. Ethan also addresses the elephant in the room: the unusually consistent subjective reports from people who use SEMAX, what they actually tell us, and — critically — what they don't. And he covers the regulatory picture across the UK, EU, and US, the quality control risks of sourcing outside a licensed pharmaceutical supply chain, and what a properly designed research agenda for SEMAX would actually look like.

If you've been offered SEMAX at a clinic, or you're considering it, or you simply want to understand why the gap between online enthusiasm and clinical evidence is so wide — this is the episode to start with.

GHK-Cu — glycine-histidine-lysine complexed with copper — is one of the most structurally simple compounds in this series and one of the most mechanistically interesting. It is a tripeptide: three amino acids, naturally present in human plasma, saliva, and urine, with plasma concentrations that fall from roughly 200 nanograms per millilitre in young adults to near-undetectable levels by the time most people reach 60. That decline, and what it may mean for tissue maintenance and repair capacity across the lifespan, is the central biological question this episode addresses.

The compound was first characterised in the early 1970s by Loren Pickart, who identified it in human plasma albumin fractions and noted its capacity to stimulate liver tissue regeneration in vitro. Subsequent decades of research — predominantly preclinical, predominantly in cell culture and animal models — have built a mechanistic picture of unusual breadth. GHK-Cu appears to modulate gene expression at scale: a 2010 analysis by Pickart and colleagues identified over 4,000 human genes regulated by GHK, with a roughly equal split between upregulation and downregulation. The upregulated genes cluster around wound healing, collagen synthesis, antioxidant defence, and nerve regeneration. The downregulated genes include inflammatory mediators, oncogenes associated with aggressive tumour behaviour, and genes involved in tissue degradation.

In this episode, Dr. Ethan works through the mechanism in detail — the copper-dependent activation of superoxide dismutase, the upregulation of collagen and glycosaminoglycan synthesis, the suppression of TGF-beta 1-driven fibrosis, the activation of the Nrf2 antioxidant programme, and the VEGF-mediated angiogenic effects that underpin its wound-healing activity. He then addresses what the human evidence actually shows: robust data for topical wound healing applications, early but meaningful data for topical hair and skin applications, and a near-complete absence of completed randomised controlled trials for systemic or injectable use. The longevity application — using GHK-Cu to slow tissue ageing, support connective tissue integrity, and modulate the inflammatory environment systemically — is being actively explored in clinics across the UK, Europe, and the United States. That application is mechanistically coherent. It is not yet evidence-based in the clinical trial sense of that term. This episode explains the difference, and what it means for anyone navigating this space.

In the mid-1990s, antiretroviral therapy was transforming HIV from a death sentence into a chronic condition — and creating an unexpected syndrome in its wake. Patients on the new combinations were developing visceral fat accumulation, peripheral fat loss, dyslipidaemia, and a measurably blunted growth hormone rhythm. A small Canadian biotech in Montréal saw the lever. Native GHRH had a half-life of seven minutes, cleaved almost instantly by an enzyme called DPP-IV. Their structural innovation — adding a single trans-3-hexenoic acid group to the N-terminus — blocked the cleavage site, extended the half-life to twenty-six minutes, and made an entire pharmacology clinically viable.

That compound is Tesamorelin, and in 2010 it became one of the very few synthetic peptides ever to clear the full FDA approval pathway.

In this episode, Dr. Ethan walks through the molecule properly. The forty-four amino acid sequence, the structural modification that makes it work, and the mechanism that distinguishes it from every other growth hormone strategy: Tesamorelin doesn't introduce GH, it activates the body's own pituitary to release GH in its natural pulsatile pattern, preserving somatostatin feedback and the physiological rhythm that exogenous rhGH abolishes. The episode follows the cascade from GHRH receptor binding through cAMP and PKA activation to pulsatile GH release, hepatic IGF-1 production, and the anabolic and lipolytic effects downstream.

Then the human evidence — and this is where Tesamorelin sits in a category of its own. Two pivotal Phase III trials, fifteen years of post-marketing data, and a defined safety profile in HIV-associated lipodystrophy. Emerging Phase II data in MASLD showing meaningful reductions in hepatic fat. Exploratory work in cognitive function, sarcopenia, and healthy ageing — promising mechanistically, but not yet pivotal-trial grade.

Dr. Ethan closes with an honest 2026 assessment: what the off-label use looks like, what the safety considerations actually are, what diagnostics any responsible Tesamorelin protocol requires, and where the gap remains between mechanistic plausibility and demonstrated efficacy outside the approved population. As ever — what we know, what we don't, and what the honest picture looks like for anyone navigating this field.

The Science of Age-less Living. Hosted by Dr. Ethan Hausman-Marquis. Available on Spotify and Apple Podcasts.

In this episode of The Science of Age-less Living, Dr. Ethan explores Thymosin Alpha-1, one of the most clinically studied and widely prescribed peptides in the world. Originally isolated from the thymus gland in the 1970s, Thymosin Alpha-1 has evolved from an obscure immune peptide into a prescription immunomodulator used in more than 35 countries.

We examine the remarkable history of its discovery, the molecular mechanisms that drive its effects, and the evidence supporting its use in chronic viral infections, sepsis, oncology, vaccine enhancement, and age-related immune decline. You'll learn how Thymosin Alpha-1 influences Toll-like receptors, dendritic cells, T-cells, and natural killer cells, and why many researchers consider it one of the most biologically interesting immune-regulating peptides available today.

Most importantly, we separate evidence from speculation. Does Thymosin Alpha-1 genuinely support healthy ageing? Can it help counter immunosenescence? What do decades of clinical data tell us, and where do the limits of the science remain?

No hype. No marketing. Just a deep dive into the biochemistry, clinical evidence, safety profile, and real-world applications of one of the most important peptides in modern immunology.

Klotho was discovered in 1997 when a disrupted gene caused mice to develop every hallmark of premature ageing within weeks — osteoporosis, arteriosclerosis, muscle wasting, cognitive decline — and die at a fraction of their expected lifespan. The inverse experiment extended lifespan by twenty to thirty percent. The protein was named after Clotho, the Greek Fate who spins the thread of life. It remains one of the most studied proteins in longevity biology nearly three decades later.

In this episode, Dr. Ethan Hausman-Marquis examines Klotho from the ground up: the critical distinction between transmembrane α-Klotho and its circulating shed form sKlotho; how the FGF23 co-receptor mechanism explains the accelerated ageing phenotype of Klotho deficiency; what five separate longevity-associated pathways — including IGF-1/PI3K suppression, Wnt/β-catenin inhibition, Nrf2 antioxidant activation, and TGF-beta fibrosis suppression — suggest about why this protein matters so broadly; and why circulating Klotho levels decline by approximately 40 percent between the ages of 40 and 80.

The human evidence is examined honestly: what the large prospective cohort studies actually show, what the KL-VS genetic variant data adds to the causal argument, what the 2014 Cell Reports cognitive findings mean for neurodegeneration research, and why the interventional human data — despite the extraordinary preclinical picture — is essentially non-existent.

The evidence base, the interventional frontier, the exercise and vitamin D data, and the honest assessment of where exogenous Klotho research actually stands in 2026 — all of it, examined without hype.

If you're researching Klotho supplementation, Klotho and ageing, Klotho and cognitive decline, or the science behind longevity peptides and anti-ageing medicine, this is the rigorous account the subject deserves.

Keywords: Klotho · alpha-Klotho · sKlotho · Klotho longevity · Klotho and ageing · Klotho peptide · Klotho cognitive decline · Klotho supplement · FGF23 · longevity medicine · anti-ageing science · longevity podcast · peptide science · ageing biology · longevity research · Dr. Ethan Hausman-Marquis · The Science of Age-Less Living · The Catalyst Clinic · peptide therapy London · longevity clinic London · biohacking · epigenetics · IGF-1 · Wnt signalling · Nrf2 · TGF-beta · KL-VS · Klotho gene

This is the first episode in a new series: the Top 20 Peptides. Over twenty episodes, Dr. Ethan Hausman-Marquis examines the most researched compounds in longevity and regenerative medicine — the real biochemistry, the honest evidence base, and the regulatory context behind each one. No hype, no discount codes. Just the science.

We start with BPC-157. Derived from a naturally occurring sequence in human gastric juice and studied for over thirty years, it's the peptide that put this whole field on the map — and one of the most misunderstood molecules in it. This episode covers how it was discovered, what its proposed mechanisms actually are at the molecular level, what the preclinical research genuinely shows across five areas of investigation, and why a 2025 systematic review of 544 published articles found exactly one human clinical study meeting inclusion criteria.

The evidence base, the open safety questions, the FDA compounding restriction, the WADA prohibition — all of it, examined honestly.

If you're new to peptide science, this series is the foundation. If you're already in the space, this is the rigorous re-examination it deserves.

The Age-Less Top 20 Peptides series. Episode 1 of 20.

In this episode of The Science of Age-less Living, Dr. Ethan Hausman-Marquis reveals why many people using peptide therapy only achieve partial results — and how an easy, science-backed fix can unlock the missing 30–40% of their potential.

He explains that peptides (such as BPC-157, CJC-1295/Ipamorelin, Thymosin Alpha-1, and collagen peptides) are powerful signaling molecules that tell your body to heal, regenerate, reduce inflammation, and optimize hormones. However, they cannot create results out of nothing. They require specific nutrient co-factors, low inflammation, and proper cellular conditions to deliver their full effects.

He breaks down the key synergies between peptides and supplements, highlighting four powerful “Power Pairings”:

• BPC-157 + Zinc & Magnesium for superior gut healing and tissue repair
• CJC-1295/Ipamorelin + Vitamin D & Zinc for maximized growth hormone response
• Collagen Peptides + Vitamin C for better skin, joints, and connective tissue
• Thymosin Alpha-1 + Vitamins C, D & Selenium for stronger immune function

The episode also covers the most common deficiencies (magnesium, Vitamin D, zinc, and omega-3s) that quietly sabotage peptide results, the importance of blood testing, and practical baseline stacks.

Dr. Ethan shares how The Catalyst Clinic uses comprehensive testing, personalized analysis through their AI system AURION™, and custom-compounded daily supplement packets to make optimal stacking effortless and highly effective.

Key Takeaway: Peptides signal. Supplements supply. Stack them intelligently, and you’ll move from good results to truly transformative Age-less Living.

Most longevity medicine is built on guesswork, trends, and short-term thinking. In this episode, Dr. Ethan Hausman-Marquis breaks down why that approach fails—and what actually drives measurable, long-term results.

Inside The Catalyst Clinic, longevity is treated as a structured clinical system, not a collection of supplements or peptides. From strict patient selection to deep data collection, advanced biomarker analysis, and fully personalized protocol design, every step is engineered for precision and outcomes.

You’ll learn how the clinic integrates mitochondrial optimization, inflammation control, hormonal balance, neurocognitive performance, and recovery into a tightly controlled 90-day strategy—supported by weekly coaching, continuous monitoring, and real-time iteration.

This episode walks through the full seven-step framework: selection, testing, interpretation, protocol design, implementation, monitoring, and long-term optimization. No guesswork. No generic plans. Just a repeatable system designed to improve energy, body composition, and biological age over time.

If you’re serious about moving beyond biohacking trends and building a system that actually works, this is the standard.

In this episode of The Science of Age-less Living, Dr. Ethan dives deep into the fascinating world of peptides — the tiny but powerful molecular messengers that play a central role in how we age.

You’ll discover how peptides are encoded in your genes, follow the remarkable cellular factory process of transcription and translation that builds them, and learn how these short chains of amino acids act as precise keys that unlock cell receptors and even function as transcription factors to control entire gene networks.

The episode explores the full journey: from DNA blueprint to receptor signaling, and finally to the rapid breakdown and recycling that keeps cellular communication sharp and efficient. Along the way, Dr. Hausman-Marquis explains why youthful peptide signaling is key to reducing inflammation, boosting repair, keeping stem cells active, and preventing “zombie” senescent cells.

You’ll also learn how aging affects this elegant system and simple lifestyle strategies that can help keep your peptide pipeline running smoothly for decades to come.

If you want to understand the hidden biology behind staying biologically young, this episode is for you.

In this illuminating episode of The Science of Age-less Living, Dr. Ethan Hausman-Marquis takes you on a deep dive into the very foundation of life itself: the central dogma of molecular biology.

From DNA to RNA to protein — discover how this elegant cellular assembly line governs everything from skin elasticity and energy production to repair and regeneration. Using vivid analogies, Dr. Hausman-Marquis explains why the speed and accuracy of transcription and translation are intimately linked to how we age, and how errors in this process contribute to genomic instability, protein misfolding, and inflammaging.

You’ll explore the powerful roles of peptides — nature’s precision repair crews — including GHK-Cu, Epitalon, and senotherapeutic peptides like OS-01, which fine-tune protein output, support telomere maintenance, boost collagen production, and help restore youthful gene expression.

Then, journey into the revolutionary world of siRNA (small interfering RNA) — the molecular silencers that can intercept and destroy faulty genetic instructions before they cause harm. Learn how this Nobel Prize-winning technology is moving from rare disease treatments into the frontier of longevity, with companies like Junevity targeting master transcription factors to reprogram aged cells.

Whether you’re passionate about longevity, skincare, metabolic health, or simply want to understand how your body really works, this episode will leave you with a clearer picture of how science is transforming aging from an inevitable decline into a process we can actively influence.

In this profound episode of The Science of Age-Less Living, host Dr. Ethan Hausman-Marquis explores the atomic fate of the human body after death—specifically through cremation—as a lens to reframe longevity, aging, and what it truly means to preserve life.

Drawing on Carl Sagan’s iconic line that “we are made of star stuff,” the episode traces the cosmic origins of the body’s atoms (carbon from stellar cores, nitrogen, calcium, iron, and more) and explains their remarkable durability. During cremation at 1,400–1,800°F:

• No atoms are destroyed—only molecular bonds break.
• Water vaporizes and rejoins the global hydrological cycle.
• Carbon oxidizes into CO₂, entering the planetary carbon cycle (photosynthesis, plants, animals, oceans).
• Nitrogen returns mostly as inert N₂ gas, later fixed by bacteria for reuse in new proteins and DNA.
• The mineral portion (calcium phosphate in bones) remains as processed “ashes,” but even these slowly weather back into soil and ecosystems over time.

The core insight is the distinction between atoms (effectively immortal on human timescales, constantly cycling through Earth’s systems even while we’re alive) and pattern (the highly ordered, low-entropy arrangement of those atoms that creates consciousness, memory, identity, and function). Cremation—or any form of decomposition—dissolves the pattern irreversibly through entropy, while the atoms themselves disperse and continue participating in the universe’s chemistry.

This perspective reframes age-less living and longevity science: interventions like mitochondrial support, metabolic optimization, peptides, sleep, strength training, and cognitive protection are not attempts to defy physics or achieve literal immortality. Instead, they are deliberate efforts to maintain pattern coherence—to slow the encroachment of entropy and extend the time during which seven octillion star-forged atoms remain arranged in a way that can heal, learn, love, create, and reflect on existence.

Ultimately, the episode offers clarity rather than morbidity: your atoms were here billions of years before you and will circulate for billions after, reintegrating into clouds, forests, future organisms, and perhaps other conscious beings. But the specific, fragile pattern that is you is temporary and irreplaceable. That finitude makes every moment of vitality, agency, and connection more urgent and precious.

The goal of age-less living, therefore, is not to prevent the inevitable transformation of matter, but to maximize the quality, clarity, and meaning of the pattern while it endures—living younger, for longer, in full awareness of our place in an immense, continuous cosmic cycle.

In this episode of The Science of Age-less Living, Dr. Ethan cuts through the noise around “anti-aging” and peptide culture to lay out what longevity medicine actually is: evidence-based risk management, not influencer-driven optimization. You’ll hear why the biggest threats to lifespan and healthspan are still cardiovascular disease, metabolic dysfunction, neurodegeneration, and cancer—and why no peptide stack can compensate for ignored biomarkers, unchecked ApoB, poor glucose control, or low fitness.

Dr. Ethan breaks longevity into a practical hierarchy: Tier 1 fundamentals (sleep, VO2 max, ApoB control, insulin sensitivity), Tier 2 amplifiers (mitochondrial function, inflammation control, physiologic hormone optimization), and only then Tier 3—targeted peptides used selectively, with clear indications and lab monitoring. He highlights where specific peptides may have legitimate utility in narrow clinical contexts, and calls out the most common “longevity clinic” hype—from exosomes and stem-cell claims to reckless GLP-1 use in already-lean patients.

The takeaway is simple: peptides can be useful tools, but they’re not the foundation. Real longevity comes from mastering the boring, proven levers—and using advanced interventions only when the data says you actually need them.

In this episode of The Science of Age-less Living, Dr. Ethan argues that aging is not primarily about accumulated damage (oxidative stress, inflammation, telomere shortening), but a loss of timing and synchronization in the body’s biological clocks.

The master clock (SCN in the brain) and peripheral clocks in organs coordinate hormones, gene expression, metabolism, repair, and immunity in precise rhythms—strong and harmonious in youth, but increasingly damped and desynchronized with age. This breakdown causes inefficient repair, unchecked inflammation, and rapid functional decline, explaining why organs age at different rates and why short-term sleep loss accelerates aging markers faster than expected.

Sleep is highlighted as the key synchronizer (via melatonin, growth hormone pulses, etc.), while continuous, non-rhythmic interventions (daily NAD+ boosters, peptides, supplements) often backfire by flattening natural oscillations and worsening discord.

The solution: prioritize rhythm restoration through optimized sleep, light-dark alignment, and pulsed, cyclical, personalized protocols that respect the body’s innate timing rather than brute-force constant stimulation. By re-synchronizing the “orchestra,” vitality and healthy lifespan can be meaningfully extended.

In this episode of The Science of Ageless Living, Dr. Ethan Hausman-Marquis unpacks autoimmune fatigue in conditions like MS, lupus, and rheumatoid arthritis—and why it’s so often misunderstood. Fatigue isn’t laziness or deconditioning; it’s a biological safety response to chronic inflammation.

He explains how inflammation disrupts neurotransmitters, autonomic balance, and oxidative stress, with mitochondria at the center. In autoimmune disease, mitochondria intentionally downshift energy production to protect cells from damage—an intelligent adaptation, not failure.

A key takeaway: more energy isn’t always better. Aggressive interventions like NAD+ or stimulants can override the body’s protective signals, increasing the risk of flares. True repair happens in parasympathetic, rest-and-digest states.

The episode outlines a smarter strategy built on timing, low-and-slow dosing, and restraint—prioritizing nutrition, sleep, gentle movement, and stress regulation before metabolic “boosts.” Fatigue is reframed as a signal to respect biology, not fight it.

#AutoimmuneFatigue #MitochondrialHealth #MultipleSclerosis #Lupus #RheumatoidArthritis #ChronicInflammation #NAD #LongevityMedicine #FunctionalMedicine #EnergyMetabolism #ParasympatheticHealing #TheScienceOfAgelessLiving

Why do we age? Is it simply the passage of time — or something far more precise, and far more modifiable?

In this episode of The Science of Age-less Living, Dr. Ethan Hausman-Marquis takes you deep into the real biology of aging, revealing why growing older is not an inevitable countdown, but a consequence of accumulated cellular damage and declining repair capacity.

You’ll learn why aging is best understood as a systems-level failure — a breakdown in information, energy, and repair — rather than a single disease. We explore how DNA damage accumulates over time, why epigenetic regulation drifts and causes identical twins to age differently, and how loss of proteostasis leads to protein misfolding and neurodegenerative disease.

The episode then zooms into the cell’s power plants: mitochondria. You’ll discover why mitochondrial dysfunction may be the true biological clock of aging, how redox imbalance and failed mitophagy turn cells into energy-starved “zombie” states, and why restoring mitochondrial health has such wide-ranging effects on longevity.

We break down the critical role of NAD⁺ — the cell’s universal energy currency — explaining how its age-related decline impairs DNA repair, silences longevity genes, and accelerates cellular dysfunction, and why NAD⁺ restoration has become a cornerstone of modern longevity medicine.

Finally, we demystify peptides. Far from hype or bro-science, peptides are revealed as precision signaling molecules that restore lost cellular communication, gently reminding cells how to behave the way they did in youth — supporting tissue repair, neuroplasticity, immune balance, and healthy growth hormone signaling.

This episode reframes aging as a treatable, measurable process — not an unavoidable fate. By the end, you’ll walk away with a clear framework for understanding how modern longevity medicine targets the root causes of aging at the cellular and molecular level, and why multi-layered, systems-based interventions are the future of healthy aging.

If you’re ready to move from passive aging to proactive longevity, this episode lays the scientific foundation.

Dr Ethan Hausman-Marquis dismantles the hype around MTHFR in this evidence-based 16:30 talk. Learn what MTHFR actually does, what common variants like C677T and A1298C mean, how homocysteine, folate, B12 and lifestyle shape risk, and when testing or targeted supplementation is appropriate. Perfect for evidence-based health seekers confused by genetic marketing and “methylation” protocols—this calm guide shows how to integrate MTHFR responsibly into clinical care without fear or oversimplification. Watch for clear clinical vignettes, practical treatment principles, and communication tips for patients. If this helped, please like and share with someone told they “have MTHFR.”

#MTHFR #Methylation #Homo

Dive into SS-31 Explained: Unlock Youthful Energy at the Mito Level — a 6:45 deep-dive on SS-31 (Elamipretide), mitochondrial health, and the latest 2025 clinical updates. Dr. Ethan breaks down mechanisms, preclinical wins, human trials, safety, and real-world anti-aging potential for longevity seekers (35–65). Learn how SS-31 targets cardiolipin, reduces ROS, boosts ATP, and why FDA approval for Barth syndrome matters for mitochondrial medicine. Perfect for anyone curious about mitochondrial dysfunction, sarcopenia, HFpEF, AMD, and translational longevity science. Like and share if you found this useful. #SS31 #Elamipretide #Mitochondria #Longevity #AntiAging #BarthSyndrome #MitochondrialHealth

OUTLINE:

00:00:00 Opening and Episode Intro

00:01:32 Chapter 1 - Introducing SS-31

00:07:06 Chapter 2 - Mechanism

00:13:45 Chapter 3 - Preclinical Studies

00:21:14 Chapter 4 - Human Trials

00:26:31 Chapter 5 - Age-less Living Benefits

00:28:46 Chapter 6 - Safety

00:30:14 Chapter 7 - Future Outlook

00:31:13 Chapter 8 - Wrap Up

Forget Peptides—Sleep Is the Real Longevity Hack — Dive into this episode of The Science of Age-less Living: a 27:30 deep-dive using stock visuals that unpacks why restorative sleep outperforms trendy fixes like peptides and stem cells for healthspan, cellular repair, cognitive resilience, and hormonal balance. Evidence-driven, practical, and tailored for longevity enthusiasts and biohackers, this episode covers sleep science, glymphatic clearance, telomeres, sleep hygiene tips, CBT‑I, wearables, and real-world strategies to optimize circadian rhythm. Follow the script word-for-word for a focused, actionable listen. If this helped you rethink your bedtime, please like and share with fellow biohackers. #Longevity #SleepHygiene #Biohacking #Healthspan #CircadianRhythm

OUTLINE:

00:00:00 Opening and Setup

00:01:27 The Lure of Longevity Hype

00:11:08 Stem Cells vs Reality

00:16:00 The Science of Sleep

00:22:40 Culture, Psychology, and Practical Tools

00:28:50 Vision and Call to Action

Join Dr. Ethan at The Catalyst Clinic for "Precision Longevity: Real Cases, Real Results" — a deep dive into evidence-based longevity medicine. Follow patient case studies on tendon regeneration, chronic fatigue, hair/skin restoration, and cognitive recovery using precision diagnostics, NAD+, targeted peptides (BPC-157, TB-500, MOTS-c, SS-31, GHK-Cu, KPV, Semax, Selank), red-light therapy, exosomes, and AURION™ AI-guided protocols. Learn how systems-level medicine, mitochondrial support, circadian optimization, and nutrition combine to restore function, resilience, and quality of life for longevity seekers aged 35–55. Like and share if this brought clarity or hope. More at thecatalystclinic.com. and Instagram @thecatalytclinic #Longevity #PrecisionMedicine #PeptideTherapy #NAD #RegenerativeMedicine

Dr. Ethan breaks down the science behind reversing biological age in The Age-less Code: Reversing Time with Peptides, Stem Cells & Gene Therapy. This episode from The Catalyst Clinic explores peptides (BPC-157, TB-500, GHK‑Cu, Epithalon), stem cells & exosomes, and gene/epigenetic therapies—connecting practical clinical use with the future of longevity and regenerative medicine. Ideal for longevity seekers (35–65) curious about biological age, NAD, sirtuins, exosome therapy, and personalized protocols. All visuals use licensed stock media. Like and share if you found this valuable. Learn more at thecatalystclinic.com and follow @thecatalystclinic for updates. #Longevity #RegenerativeMedicine #Peptides #StemCells #GeneTherapy

00:00:00 Opening

00:00:38 The Nature of Aging

00:01:38 The Peptide Revolution

00:04:37 Stem Cells and Exosomes

00:07:04 Gene Therapy and Epigenetic Reprogramming

00:09:28 The Continuum of Repair

00:10:53 Clinical Translation and Case Reflections

00:12:20 The Philosophy of Ethical Rejuvenation

00:12:58 The Future Horizon

00:13:53 Closing Reflections

00:15:12 End Slate and Credits

Dive into the remarkable world of peptides with Dr. Ethan in this enlightening episode of "The Science of Age-less Living." While BPC-157 and TB-500 often steal the spotlight, we'll uncover the hidden potential of KPV and VIP—two lesser-known peptides that hold incredible promise for healing and regeneration. Discover how KPV acts as an anti-inflammatory powerhouse, promoting gut health, while VIP serves as a multi-system modulator affecting everything from the brain to the immune system. Join us as we explore the science behind these game-changing compounds and their therapeutic applications. Like this video and share your thoughts in the comments below!

OUTLINE:

00:00:00 Welcome to The Science of Age-less Living

00:00:37 Shifting the Spotlight to KPV and VIP

00:01:02 What to Expect in This Episode

00:01:16 The Limitations of Popular Peptides

00:01:48 The "Poster Children" of Peptide Therapy

00:02:03 The Deeper Benefits of Peptides

00:02:22 The Unsung Heroes

00:02:38 KPV – The Anti-Inflammatory Powerhouse

00:02:56 Origin and Mechanism of KPV

00:03:26 How KPV Works in the Body

00:03:47 KPV in Simpler Terms

00:04:01 Clinical Relevance of KPV

00:04:24 KPV and Gut Health

00:04:55 KPV and BPC-157

00:05:04 KPV’s Expanding Role

00:05:28 Current Research on KPV

00:05:50 Anecdotal and Clinical Use of KPV

00:06:28 KPV Tolerance and Safety

00:06:34 What KPV Represents in Medicine

00:06:50 VIP – Vasoactive Intestinal Peptide

00:06:58 What VIP Is

00:07:18 VIP is More Than a Vascular Regulator

00:08:01 VIP Effects on Inflammation

00:08:18 VIP and Circadian Rhythm

00:08:36 VIP Neurons and Biological Clocks

00:08:47 Clinical Applications of VIP

00:09:25 VIP Influences Brain-Gut Communication

00:09:57 Human Trials for VIP

00:10:10 Anecdotal Use of VIP

00:10:30 VIP is a Double-Edged Sword

00:10:50 VIP is Promising for Homeostasis

00:11:06 Why Aren’t KPV and VIP More Well-Known?

00:11:12 Market Dynamics and Visibility

00:11:35 KPV and VIP Act Quietly

00:11:46 Complexity of Administration

00:11:58 KPV and Marketing Limitations

00:12:06 Access and Regulation Challenges

00:12:21 Hidden Gems of Peptide Therapy

00:12:30 The Future of KPV and VIP

00:12:33 Rise in Studies and Research

00:12:46 Cornerstones of Repair

00:12:56 VIP Could Emerge as a Leading Therapy

00:13:06 Imagine a Future with Peptide Therapy

00:13:24 Consult a Healthcare Provider First

00:13:36 Stay Curious – The Field is Evolving

00:13:44 KPV – The Quiet Powerhouse

00:13:56 VIP – The Multi-System Modulator

00:14:06 The Next Evolution in Peptide Therapy

00:14:13 Reach Out and Connect

00:14:30 Subscribe for More Longevity Science

00:14:54 Stay Curious, Stay Vital, Live Age-lessly

Dr. Ethan breaks down epigenetics and how your daily choices shape biological age in this 19:45 deep-dive. Learn DNA methylation, histone modification, non-coding RNAs, epigenetic drift, methylation clocks (Horvath, GrimAge), and practical lifestyle levers—nutrition, exercise, sleep, stress management, and environmental hygiene—to “rewrite” your cellular code. Explore cutting-edge therapies like peptides, NAD+ micro-dosing, senolytics, and partial reprogramming, plus consumer methylation tests and future epigenetic editing. Perfect for health-conscious adults 35+ seeking science-backed longevity strategies and actionable tips. If this episode helped, please like and share with someone you care about. Visit The Catalyst Clinic for more resources.

Dr. Ethan breaks down how peptide therapy is transforming perimenopause care—targeting hormone balance, mitochondrial function, inflammation, sleep, cognition, libido, and metabolic health. This 38:15 deep-dive covers Epitalon, DSIP, Semax, Selank, Kisspeptin-10, CJC-1295 + Ipamorelin, PT-141, BPC-157, Thymosin Alpha-1, NAD+ support, and practical protocols used at The Catalyst Clinic. If you’re a woman 35–55 navigating perimenopause, learn precision approaches to reduce brain fog, restore energy, protect bone and muscle, and optimize long-term health. Like and share if you found this helpful—help other women discover science-led options for thriving through midlife. #Perimenopause #PeptideTherapy #Longevity #WomensHealth #Mitochondria

00:00:00 Opening

00:02:04 Differentiating Perimenopause

00:03:46 Cellular Mechanisms

00:06:54 Peptides 101

00:09:15 Mechanisms and Examples

00:13:30 Categories and Protocols

00:18:18 Sexual Health and Energy; Inflammation and Longevity

00:21:35 Synergistic Protocols

00:23:43 Evidence

00:28:14 Case Studies

00:30:59 Risks, Ethics, and Regulation

00:35:55 Sum Up

Dive into polygenic risk scores (PRS) and discover how your genetic blueprint can inform personalized longevity strategies. Dr. Ethan Hausman-Marquis breaks down genome sequencing, five major genetic pathways to aging (DNA repair, metabolism, inflammation, mitochondria, neurodegeneration), and real-world clinical applications from The Catalyst Clinic.

Learn how PRS can shift prevention from one-size-fits-all to truly individualized interventions—while understanding limits like population bias and probabilistic risk. Perfect for longevity science fans curious about precision medicine, NAD+, peptides, and building cognitive and mitochondrial resilience. If this episode helped you, please like and share with someone interested in age-less living. #PolygenicRiskScore #Longevity #PrecisionMedicine #AntiAging #Genomics

OUTLINE:

00:00:00 Title and Introduction

00:02:35 Genes Aren't Destiny

00:06:19 What Is a Polygenic Risk Score?

00:10:28 Two Patients Example

00:13:17 Five Major Pathways

00:20:58 Limitations and Caveats

00:25:30 Clinical Application

00:27:56 Emotional Impact

00:29:58 Closing Reflection

In this episode of The Science of Age-less Living, Dr. Ethan—doctor, molecular biologist, athlete, and regenerative medicine expert—explores the fascinating world of peptides and their essential role in cellular health, performance, and longevity. This episode demystifies peptides, describing them as short chains of amino acids that function as “project managers” within our cells. Using engaging construction site analogies, Dr. Ethan explains how peptides are created from DNA instructions, undergo precise modifications, and are tightly regulated to perform specific tasks. Unlike proteins, peptides are shorter and act mainly as messengers and coordinators, directing when and how cells grow, heal, and defend themselves.Listeners learn about:

• The biological processes of transcription and translation, which turn DNA blueprints into peptide messengers.
• How peptides signal, regulate, and coordinate vital cellular functions—like hormone release, tissue repair, and immune defense.
• The dynamic regulation, modification, and recycling of peptides, and their impact on age-related health and disease.
• The expanding potential of peptide-based medicine, from anti-aging therapies to immune boosters.

Dr. Ethan concludes by emphasizing the adaptability and responsiveness of the body’s peptide system, inspiring listeners to make informed, proactive choices to support their own health and longevity. The episode encourages curiosity, self-education, and an active role in personal wellness, celebrating peptides as unsung heroes at the heart of age-less living.

This podcast episode of "The Science of Age-less Living," hosted by Dr. Ethan , delves into the burgeoning world of peptide therapies and their role in modern medicine, particularly in the context of longevity and wellness. The discussion highlights the science behind peptides—short chains of amino acids with targeted effects on bodily processes—and contrasts their rapid rise in the wellness community with the traditional, cautious approach of Big Pharma. Through real-world case studies, market data, and expert insights, the episode explores whether peptides are a disruptive force or a complementary innovation, examining regulatory challenges, safety concerns, and rampant misinformation in the marketplace. Ultimately, the narrative underscores that while peptides hold immense promise for age-less living and transformative healthcare, their integration requires rigorous science, informed consumer choices, and collaboration between innovators and established pharmaceutical companies to maximize benefits and minimize risks.

Are NAD+ supplements the key to age-less living, or could they pose a cancer risk? In this episode of "The Science of Age-less Living," Dr. Ethan Hausman-Marquis delves into the complexities surrounding nicotinamide adenine dinucleotide (NAD+).

Discover its crucial role in energy production, DNA repair, and cellular health, as well as the rising popularity of NAD+ supplements.

We’ll examine the scientific evidence linking NAD+ to cancer growth and discuss the implications for those with a history of cancer. With caution advised for certain individuals, learn how to navigate the fascinating landscape of NAD+ supplementation.

Join us as we separate fact from fiction and empower your health journey!

#NADplus #AgingScience #HealthAndWellness #CancerResearch #AgeLessLiving

OUTLINE:

00:00:00 The Foundation of Age-less Science or Cancer Curse?

00:02:33 NAD+ Basics and Its Importance

00:06:16 Hype vs. Science

00:09:51 NAD+ and DNA Repair

00:11:23 NAD+ and the Immune System

00:13:01. Cancer Cells Hijacking NAD+

00:15:54. Concerns About NAD+ Supplementation and Cancer

00:17:16. NAD+'s Dual Role in Cancer Biology

00:18:44. Expert and Regulatory Perspectives on NAD+

00:22:22. Recommendations and Conclusion

Can a peptide hold the key to age-less vitality? Join Dr. Ethan on The Science of Age-Less Living as he delves into the science behind testosterone's crucial role in aging and explores the potential of Testagen, a peptide bioregulator, to support natural testosterone function. Discover the theoretical mechanisms, potential benefits for energy, muscle, and overall well-being, and the critical importance of approaching such interventions with caution and expert medical guidance.

00:00:00. Introduction to Age-Less Living

00:00:30. The Quest for Longevity

00:00:49. The Role of Testosterone

00:01:05. Understanding Testosterone

00:01:29. The Challenge of Aging

00:01:57. Symptoms of Testosterone Decline

00:02:25. Long-Term Health Implications

00:03:09. Maintaining Healthy Levels

00:03:37. Exploring Testagen

00:04:02. What is Testagen?

00:04:32. How Testagen Might Work

00:05:12. Connecting to Longevity

00:05:41. Caution and Critical Thinking

00:06:21. Longevity Medicine Philosophy

00:06:50. Hormonal Optimization

00:07:29. Personalized Medicine and Monitoring

00:08:08. Caution and Controversy

00:08:38. Potential Risks and Unknowns

00:09:17. Theoretical Benefits vs. Unknown Risks

00:09:38. The Non-Negotiable

00:09:59. Individual Assessment

00:10:11. Synergy and Integration

00:10:39. Exercise and Hormonal Environment

00:11:04. Diet and Hormonal Function

00:11:29. Longevity Supplements and Hormonal Health

00:11:56. Building a Comprehensive Plan

00:12:23. Understanding Potential Interactions

00:12:34 Conclusion and Final Thoughts

00:13:09 Grounded in Perspective

00:13:46. Empowering Knowledge

00:14:00. Final Words

00:14:14. Closing

Today, Dr Ethan dives into a topic that's close to his heart, and likely to many of yours: ADHD. For decades, stimulants have been the go-to treatment, but what if there's more to the story? What if we could support brain function in a way that complements, or even transcends, traditional approaches?

In this episode, we're going beyond the familiar, and venturing into the realm of NAD+. Yes, that NAD+ – the cellular powerhouse we often associate with longevity. But could it also be a key player in managing ADHD? We'll explore the science, the potential benefits, and the practical considerations of using NAD+ as a complementary approach. From cellular energy to neurotransmitter balance, we'll uncover how this fascinating molecule might offer new hope for those seeking a more holistic path to clarity and focus. So, buckle up, because we're about to delve deep into the cellular level, and explore a potential game-changer in ADHD management. Let’s get started.

00:00:00 Introduction

00:01:25. The ADHD Challenge

00:02:29. Introduction to NAD+

00:03:36. NAD+ and Brain Health

00:05:06. Potential Benefits of NAD+

00:05:50. Current Research and Future Directions

00:07:18. Holistic ADHD Management

00:10:53. Practical Considerations for NAD+

00:14:10. Conclusion

00:16:11. Call to Action

In this episode, we delve into the cutting edge of aging research, exploring a truly groundbreaking molecule: FOXO4-DRI. This peptide has the scientific community buzzing with its potential to fundamentally reshape our understanding of aging and cellular health by targeting rejuvenation at the most basic level. Join us as we unpack the science behind FOXO4-DRI and its implications for our quest to not just live longer, but better.

OUTLINE:

00:00:00 Introduction

00:00:57 The Quest for Longevity

00:01:23 Understanding Cellular Senescence

00:02:37 Introducing FOXO4-DRI

00:03:06 The Science Behind FOXO4-DRI

00:07:33 Mechanism of Action

00:12:45 Research and Potential Applications

00:17:12 Ethical Considerations

00:19:43 Conclusion

In this episode, we delve into the cutting edge of aging research, exploring a truly groundbreaking molecule: FOXO4-DRI. This peptide has the scientific community buzzing with its potential to fundamentally reshape our understanding of aging and cellular health by targeting rejuvenation at the most basic level. Join us as we unpack the science behind FOXO4-DRI and its implications for our quest to not just live longer, but better.

OUTLINE:

00:00:00 Introduction

00:00:57 The Quest for Longevity

00:01:23 Understanding Cellular Senescence

00:02:37 Introducing FOXO4-DRI

00:03:06 The Science Behind FOXO4-DRI

00:07:33 Mechanism of Action

00:12:45 Research and Potential Applications

00:17:12 Ethical Considerations

00:19:43 Conclusion

In this episode of "The Science of Age-Less Living," Dr. Ethan explores the revolutionary world of bioregulatory peptides. These short chains of amino acids act as messengers within the body, regulating crucial biological processes. The podcast delves into the science behind these peptides, explaining how they function as a "communication network" for cells, promoting healing, enhancing recovery, and boosting immune function. Dr. Ethan discusses the applications of peptides in medicine, showcasing their ability to accelerate tissue repair (BPC-157), modulate immune responses (Thymosin Alpha-1), and slow degenerative diseases.

The episode further examines the transformative impact of peptides in aesthetic medicine, highlighting their role in stimulating collagen production (GHK-Cu), improving skin elasticity, and promoting hair growth (PTD-DBM). In the realm of fitness, peptides like IGF-1 LR3 and TB-500 are shown to enhance muscle repair, growth, stamina, and performance. The podcast also addresses Testogen, a peptide used for hormone health, particularly testosterone optimization.

OUTLINE:

00:00:00 Introduction to The Science of Age-Less Living

00:03:26 What Are Bioregulatory Peptides?

00:05:04 How Do Bioregulatory Peptides Work?

00:05:46 Examples of Bioregulatory Peptides

00:07:44 Applications of Bioregulatory Peptides in Medicine

00:11:05 Peptides in Aesthetic Medicine and Anti-Aging

00:13:10 Peptides in Fitness and Performance

00:16:52 The Future of Bioregulatory Peptides

To learn more about bioregulatory peptides, contact The Catalyst Clinic! Click here.

Discover the science behind caloric restriction and its profound impact on longevity in this video. Join Dr. Ethan as he unpacks the intricate biochemical pathways—like insulin signaling and the mTOR pathway—that connect calorie intake to aging. Learn how reducing calories (without sacrificing nutrients) can lower oxidative stress, inflammation, and promote cellular repair. Whether you're curious about optimizing health or extending lifespan, this episode is your guide to living an "Age-Less" life. Don't miss practical tips on implementing caloric restriction safely for a healthier future!

OUTLINE:

00:00:00 Introduction

00:02:29 Understanding Caloric Restriction

00:06:41 Biochemical Pathways Involved in Longevity

00:11:51 The Science of Aging and Caloric Restriction

00:15:53 Practical Considerations and Takeaways

00:19:23 Conclusion

Join Dr. Ethan, a leading medical innovator and aesthetic and longevity pioneer, in this enlightening episode of The Science of Age-Less Living, where we explore the fascinating biology of aging and the cutting-edge therapies that aim to slow it down.

From understanding the roles of cellular senescence and telomere shortening to delving into groundbreaking treatments like Epithalon peptide therapy, senolytics, and stem cell research, this episode unpacks the science behind living longer and healthier lives. Dr. Ethan also discusses the ethical implications of anti-aging therapies and speculates on future breakthroughs in longevity science.

Whether you're curious about the secrets of healthy aging or eager to learn about the latest advancements, this episode provides a comprehensive guide to the future of aging research. Stay tuned for insights that could transform how we approach aging!

00:00:00 Introduction

00:00:33 Exploring the Science of Aging and Emerging Therapies

00:02:20 The Biology of Aging

00:03:38 Cellular Senescence

00:05:46 Telomere Shortening

00:08:34 Peptide Therapy Using Epithalon

00:12:34 Other Therapeutic Interventions

00:18:57 Future Perspectives in Aging Research

00:26:16 Conclusion and Recap

Visit The Catalyst Clinic at: https://www.thecatalystclinic.com/wellness/peptide-therapy-london

Welcome to The Science of Age-Less Living, a podcast hosted by Dr. Ethan, a medical innovator and aesthetic pioneer dedicated to unlocking the secrets of living not just longer, but better. Broadcasting from The Catalyst Clinic in London, New York, and Amsterdam, this podcast delves into cutting-edge science and practical strategies for optimizing health and longevity.

In today’s episode, we’re exploring the fascinating world of NAD+—a vital coenzyme central to energy production, DNA repair, and cellular health. As we age, NAD+ levels naturally decline, impacting our metabolism, mitochondrial function, and overall vitality. We’ll uncover how this process affects aging and share actionable strategies, from lifestyle changes to supplementation, to help you maintain optimal NAD+ levels for a healthier, more vibrant life.

00:00:00 Introduction to The Science of Age-Less Living

00:01:50 What is NAD+ and How Does it Work?

00:04:07 NAD+ and Aging

00:05:53 Strategies to Boost NAD+ Levels

00:07:42 Practical Takeaways and Recommendations

00:08:33 Conclusion

Visit The Catalyst Clinic at: https://www.thecatalystclinic.com/wellness/peptide-therapy-london

In this episode, Dr Ethan dive into the transformative world of gene editing—specifically its potential to revolutionize longevity medicine. From the basics of CRISPR technology to cutting-edge research targeting age-related diseases like Alzheimer’s and heart disease, we’ll uncover how gene editing is unlocking the secrets of healthier, longer lives.

We’ll also explore the ethical considerations, societal implications, and public perceptions shaping the future of this revolutionary field.

Whether you’re a scientist, a health enthusiast, or just curious about the possibilities of aging better, this thought-provoking conversation will leave you inspired and informed about how gene editing could redefine what it means to grow older.

Tune in and join the journey to age-less living!

00:00:00 Introduction

00:00:32 Gene Editing and Aging

00:02:09 Understanding Gene Editing

00:03:19 CRISPR Technology

00:04:35 History of Gene Editing

00:06:28 Current Research in Gene Editing

00:11:16 Potential Benefits for Age-Related Diseases

00:13:36 Ethical and Societal Implications

00:16:11 Public Perception and Acceptance

00:19:57 Future Directions in Gene Editing

00:25:16 Conclusion

Visit The Catalyst Clinic at: https://www.thecatalystclinic.com/wellness/peptide-therapy-london

The Science of Age-Less Living" — hosted by Dr. Ethan, medical innovator, aesthetic pioneer, and lifelong explorer of the human body’s incredible potential — is your ultimate guide to living not just longer, but better. Broadcasting from The Catalyst Clinic with locations in London, New York, and Amsterdam, this podcast dives deep into the cutting-edge science of longevity, regenerative medicine, and optimal health.

In this episode, we uncover the secrets of BPC-157, a powerful peptide nicknamed the "miracle molecule" for its extraordinary ability to heal the gut, repair tissues, and even modulate gene expression. Where did it come from? How does it work? And what’s happening at the genomic level when BPC-157 is in action?

Join Dr. Hausman-Marquis as he explores the discovery of BPC-157, its role in gut health and tissue repair, and the groundbreaking research that’s expanding its applications to tendons, ligaments, brain health, and beyond. From its ability to promote blood vessel growth and restore tight junctions in the gut to its impact on inflammation and gene expression, this episode breaks down the science behind BPC-157 in an easy-to-follow, engaging way.

Whether you’re curious about peptides, fascinated by epigenetics, or simply seeking new ways to enhance your health and vitality, this episode is a must-listen. Buckle up—because we’re about to embark on a journey into the molecular world of healing and regeneration!

00:00:00 Introduction

00:01:25 The Discovery of BPC-157

00:02:34 How Does BPC-157 Work in the Gut?

00:04:18 Exploiting BPC-157’s Healing Properties in Research

00:05:27 The Biological Mechanism at the Genomic Level

00:07:24 Why BPC-157 is a Game-Changer

00:08:16 What’s Next for BPC-157?

00:08:46 Conclusion

Visit The Catalyst Clinic at: https://www.thecatalystclinic.com/wellness/peptide-therapy-london